Clinical Trials in Baltimore

Showing 2781-2800 of 20,142 trials

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

NCT06835972

The researchers are doing this study to find out whether the combination of abemaciclib and cabozantinib is a safe and effective treatment for people with metastatic clear cell renal cell carcinoma (ccRCC) and translocation-associated renal cell cancer (tRCC). The researchers will test different doses of the study drugs to find the highest doses that cause few or mild side effects in participants.

Metastatic Renal Cell CarcinomaTranslocation Renal Cell Carcinoma

Memorial Sloan Kettering Cancer Center43 participantsStarted Feb 2025

Baltimore, Maryland, United States • Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States +5 more locations

Active Not RecruitingPhase 3< 1 mile

A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)

NCT03246529

A total of 122 subjects were randomized into the study and investigated in the double-blind placebo-controlled setting to assess the efficacy and safety of G-CSF + BL-8040 as compared to G-CSF + placebo.

Multiple Myeloma

BioLineRx, Ltd.180 participantsStarted Mar 2018

Los Angeles, California, United States • Gainesville, Florida, United States • Miami, Florida, United States +15 more locations

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)

Find Trials by Condition in Baltimore

Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

Artificial Urinary Sphincter Clinical Outcomes

Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Evaluating Modes of Influenza Transmission 2b Baseline SAR

Safety, Tolerability, and Bioeffects of Alirocumab in Non-treatment Seeking Heavy Drinkers

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression

A Study of DM005 in Patients With Advanced Solid Tumors

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Prostate Active Surveillance Study

A Study of Cytisinicline for Smoking Cessation in Adult Smokers

Veterans Coordinated Community Care (3C) Study

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)

Harm Reduction for Smokers With Mental Illness

Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma